BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

294 related articles for article (PubMed ID: 10091764)

  • 1. Pelvic Ewing sarcoma: a retrospective analysis of 241 cases.
    Hoffmann C; Ahrens S; Dunst J; Hillmann A; Winkelmann W; Craft A; Göbel U; Rübe C; Voute PA; Harms D; Jürgens H
    Cancer; 1999 Feb; 85(4):869-77. PubMed ID: 10091764
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Which Factors Are Associated with Local Control and Survival of Patients with Localized Pelvic Ewing's Sarcoma? A Retrospective Analysis of Data from the Euro-EWING99 Trial.
    Andreou D; Ranft A; Gosheger G; Timmermann B; Ladenstein R; Hartmann W; Bauer S; Baumhoer D; van den Berg H; Dijkstra PDS; Dürr HR; Gelderblom H; Hardes J; Hjorth L; Kreyer J; Kruseova J; Leithner A; Scobioala S; Streitbürger A; Tunn PU; Wardelmann E; Windhager R; Jürgens H; Dirksen U;
    Clin Orthop Relat Res; 2020 Feb; 478(2):290-302. PubMed ID: 31580267
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Prognostic factors and patterns of relapse in ewing sarcoma patients treated with chemotherapy and r0 resection.
    Pan HY; Morani A; Wang WL; Hess KR; Paulino AC; Ludwig JA; Lin PP; Daw NC; Mahajan A
    Int J Radiat Oncol Biol Phys; 2015 Jun; 92(2):349-57. PubMed ID: 25772182
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Primary metastatic (stage IV) Ewing tumor: survival analysis of 171 patients from the EICESS studies. European Intergroup Cooperative Ewing Sarcoma Studies.
    Paulussen M; Ahrens S; Burdach S; Craft A; Dockhorn-Dworniczak B; Dunst J; Fröhlich B; Winkelmann W; Zoubek A; Jürgens H
    Ann Oncol; 1998 Mar; 9(3):275-81. PubMed ID: 9602261
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Nonmetastatic pelvic Ewing sarcoma: report of the French society of pediatric oncology.
    Carrie C; Mascard E; Gomez F; Habrand JL; Alapetite C; Oberlin O; Moncho V; Hoffstetter S
    Med Pediatr Oncol; 1999 Nov; 33(5):444-9. PubMed ID: 10531567
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Chemotherapy response is an important predictor of local recurrence in Ewing sarcoma.
    Lin PP; Jaffe N; Herzog CE; Costelloe CM; Deavers MT; Kelly JS; Patel SR; Madewell JE; Lewis VO; Cannon CP; Benjamin RS; Yasko AW
    Cancer; 2007 Feb; 109(3):603-11. PubMed ID: 17177205
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The histological response to chemotherapy as a predictor of the oncological outcome of operative treatment of Ewing sarcoma.
    Wunder JS; Paulian G; Huvos AG; Heller G; Meyers PA; Healey JH
    J Bone Joint Surg Am; 1998 Jul; 80(7):1020-33. PubMed ID: 9698007
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Surgical indications for Ewing's sarcoma of the pelvis.
    Yang RS; Eckardt JJ; Eilber FR; Rosen G; Forscher CA; Dorey FJ; Kelly CM; al-Shaikh R
    Cancer; 1995 Oct; 76(8):1388-97. PubMed ID: 8620413
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Multidisciplinary treatment of primary Ewing's sarcoma of bone. A 6-year experience of a European Cooperative Trial.
    Jürgens H; Exner U; Gadner H; Harms D; Michaelis J; Sauer R; Treuner J; Voûte T; Winkelmann W; Winkler K
    Cancer; 1988 Jan; 61(1):23-32. PubMed ID: 3334950
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Local recurrence, rate and sites of metastases, and time to relapse as a function of treatment regimen, size of primary and surgical history in 62 patients presenting with non-metastatic Ewing's sarcoma of the pelvic bones.
    Evans R; Nesbit M; Askin F; Burgert O; Cangir A; Foulkes M; Gehan E; Gilula L; Kissane J; Makley J
    Int J Radiat Oncol Biol Phys; 1985 Jan; 11(1):129-36. PubMed ID: 3881374
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Histological response to neoadjuvant chemotherapy in localized Ewing sarcoma of the bone: A retrospective analysis of available scoring tools.
    Righi A; Pacheco M; Palmerini E; Carretta E; Gambarotti M; Longhi A; Magagnoli G; Sbaraglia M; Manfrini M; Picci P; Dei Tos AP
    Eur J Surg Oncol; 2021 Jul; 47(7):1778-1783. PubMed ID: 33622576
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Evaluation of prognostic factors in a tumor volume-adapted treatment strategy for localized Ewing sarcoma of bone: the CESS 86 experience. Cooperative Ewing Sarcoma Study.
    Ahrens S; Hoffmann C; Jabar S; Braun-Munzinger G; Paulussen M; Dunst J; Rübe C; Winkelmann W; Heinecke A; Göbel U; Winkler K; Harms D; Treuner J; Jürgens H
    Med Pediatr Oncol; 1999 Mar; 32(3):186-95. PubMed ID: 10064186
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Improved Prognosis for Patients with Ewing Sarcoma in the Sacrum Compared with the Innominate Bones: The Scandinavian Sarcoma Group Experience.
    Hesla AC; Tsagozis P; Jebsen N; Zaikova O; Bauer H; Brosjö O
    J Bone Joint Surg Am; 2016 Feb; 98(3):199-210. PubMed ID: 26842410
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Localized Ewing tumor of bone: final results of the cooperative Ewing's Sarcoma Study CESS 86.
    Paulussen M; Ahrens S; Dunst J; Winkelmann W; Exner GU; Kotz R; Amann G; Dockhorn-Dworniczak B; Harms D; Müller-Weihrich S; Welte K; Kornhuber B; Janka-Schaub G; Göbel U; Treuner J; Voûte PA; Zoubek A; Gadner H; Jürgens H
    J Clin Oncol; 2001 Mar; 19(6):1818-29. PubMed ID: 11251014
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Multimodal Treatment in Pelvic Ewing Sarcoma: A Prognostic Factor Analysis.
    Muratori F; Totti F; Cuomo P; Beltrami G; Matera D; Tamburrini A; Capanna R; Roselli G; Campanacci DA
    Surg Technol Int; 2019 May; 34():489-496. PubMed ID: 30888673
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Outcomes with nondose-dense chemotherapy for Ewing sarcoma: A practical approach for the developing world.
    Parambil BC; Vora T; Sankaran H; Prasad M; Bakshi A; Puri A; Gulia A; Qureshi S; Laskar S; Khanna N; Shah S; Ramadwar M; Kembhavi S; Chinnaswamy G; Banavali S
    Pediatr Blood Cancer; 2020 Nov; 67(11):e28604. PubMed ID: 32706522
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Ewing's sarcoma of bone. Experience with 140 patients.
    Wilkins RM; Pritchard DJ; Burgert EO; Unni KK
    Cancer; 1986 Dec; 58(11):2551-5. PubMed ID: 3768846
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Validation of a multi-modal treatment protocol for Ewing sarcoma--a report from the polish pediatric oncology group.
    Raciborska A; Bilska K; Drabko K; Chaber R; Sobol G; Pogorzała M; Wyrobek E; Połczyńska K; Rogowska E; Rodriguez-Galindo C; Wożniak W
    Pediatr Blood Cancer; 2014 Dec; 61(12):2170-4. PubMed ID: 25163763
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Adult Ewing sarcoma: survival and local control outcomes in 36 patients with metastatic disease.
    Ahmed SK; Robinson SI; Okuno SH; Rose PS; Issa Laack NN
    Am J Clin Oncol; 2014 Oct; 37(5):423-9. PubMed ID: 23388557
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Allogeneic and autologous stem-cell transplantation in advanced Ewing tumors. An update after long-term follow-up from two centers of the European Intergroup study EICESS. Stem-Cell Transplant Programs at Düsseldorf University Medical Center, Germany and St. Anna Kinderspital, Vienna, Austria.
    Burdach S; van Kaick B; Laws HJ; Ahrens S; Haase R; Körholz D; Pape H; Dunst J; Kahn T; Willers R; Engel B; Dirksen U; Kramm C; Nürnberger W; Heyll A; Ladenstein R; Gadner H; Jürgens H; Go el U
    Ann Oncol; 2000 Nov; 11(11):1451-62. PubMed ID: 11142486
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 15.